Biopharma Bucking Market Trends on Positive FDA Feedback
01 November 2024 - 4:00AM
AllPennyStocks.com
This firm’s treatment for a disfiguring skin infection has
demonstrated safety and efficacy across multiple Phase 2 and Phase
3 studies, and shares are holding their own despite
today's...
To read the full story on AllPennyStocks.com, click
here.
Appili Therapeutics (TSX:APLI)
Historical Stock Chart
From Dec 2024 to Dec 2024
Appili Therapeutics (TSX:APLI)
Historical Stock Chart
From Dec 2023 to Dec 2024